Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
98.7M
-
Number of holders
-
154
-
Total 13F shares, excl. options
-
155M
-
Shares change
-
+10.6M
-
Total reported value, excl. options
-
$916M
-
Value change
-
-$35M
-
Put/Call ratio
-
0.28
-
Number of buys
-
98
-
Number of sells
-
-67
-
Price
-
$5.92
Significant Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q2 2022
214 filings reported holding GDRX - GoodRx Holdings, Inc. - Common Stock as of Q2 2022.
GoodRx Holdings, Inc. - Common Stock (GDRX) has 154 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 155M shares
.
Largest 10 shareholders include Francisco Partners Management, LP (84.7M shares), MORGAN STANLEY (18.9M shares), VANGUARD GROUP INC (7.09M shares), LIGHT STREET CAPITAL MANAGEMENT, LLC (4.63M shares), MARSHALL WACE, LLP (3.57M shares), Silver Lake Group, L.L.C. (3.53M shares), RENAISSANCE TECHNOLOGIES LLC (3.25M shares), Petrus Trust Company, LTA (1.8M shares), MILLENNIUM MANAGEMENT LLC (1.73M shares), and Technology Crossover Management X, Ltd. (1.65M shares).
This table shows the top 154 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.